Medical image analysis dev Koios Medical raised $5 million in a new round of equity financing, according to a recently posted SEC filing.
Koios is developing an ultrasound imaging software platform that uses artificial intelligence and machine learning to provide decision support for use in diagnosing cancer, according to the company’s website.
The company’s flagship product is the Koios DS for Breast, a breast cancer diagnostic assistant. The system has won FDA clearance and is hardware agnostic, Koios said.
The company is seeking an additional $6 million in the round, which would take the total raised up to $11 million, according to the filing.
Money in the round came from a single anonymous investor, with the first sale dated as having occurred on December 28, 2018, according to the filing.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.